Sangamo and Astellas Announce Capsid License Agreement to Deliver Genomic Medicine for Neurological Diseases

Click here to view

Presentation

Poster: Process and Formulation Development for a Novel Blood-Brain Barrier Penetrant AAV Capsid

Download PDF